Type I hyperlipidemia is characterized by severely elevated levels of chylomicrons, and thus high circulating levels of cholesterol and especially triacylglycerols, and is caused by mutations of either the gene for lipoprotein lipase or its cofactor apolipoprotein C-II [22]. Here, LPL is linked to hyperlipidemia.